Optical coherence tomography angiography in multiple sclerosis: A cross-sectional study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
25
11
2019
accepted:
30
06
2020
entrez:
24
7
2020
pubmed:
24
7
2020
medline:
24
9
2020
Statut:
epublish
Résumé
To evaluate retinal axonal density and retinal capillary flow density (CFD) variations in patients affected by multiple sclerosis (MS) as documented by Optical Coherence Tomography Angiography (OCT-A). A cross-sectional study was performed in a tertiary university eye hospital on 94 eyes from 48 MS patients compared to 37 eyes from 23 matched controls. MS patients were divided in two groups: those with previous episodes of optic neuritis (MS ON+, 71.4%) and those without any previous visual complaint (no optic neuritis group, MS ON, 28.6%). Patients underwent macular and optic nerve head OCT-A with Optovue XR Avanti (Optovue, Freemont, California) after that preliminary evaluation of the ganglion cell complex (GCC) and of the retinal nerve fiber layer (RNFL) was achieved for each single eye by SD-OCT. CFD was evaluated in three different retinal layers of MS patients and controls: superficial capillary plexus (SCP), deep capillary plexus (DCP) and the choriocapillaris layer (CL). Each layer was analyzed in 18 preset subregions automatically detected by the system. CFD values were then correlated to the RNFL thickness and GCC thickness in the groups: p values were computed by t-tests between each group of MS patients and controls. A p-value of <0.05 was considered significant. A significant difference in the overall CFD values was found between ON+ and ON- patients when compared to controls in 18 subregions of SCP. Furthermore, a significant difference was found between MS patients and controls in 16 subregions analyzed corresponding to the CL layer without difference between the two MS subgroups (ON+ and ON-). OCT-A when performed at the optic nerve head level and at the macular region is characterized by a reduction of retinal perfusion in a significant portion of MS patients independently if they had a previous history of optic nerve inflammation or not.
Identifiants
pubmed: 32702050
doi: 10.1371/journal.pone.0236090
pii: PONE-D-19-32687
pmc: PMC7377434
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0236090Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Opt Express. 2012 Feb 13;20(4):4710-25
pubmed: 22418228
Acta Med Iran. 2016 Jun;54(6):382-90
pubmed: 27306345
Acta Neuropathol. 1986;71(1-2):1-10
pubmed: 3535354
Neurology. 1976 Jun;26(6 PT 2):26-8
pubmed: 944889
J Clin Neuroophthalmol. 1983 Sep;3(3):211-20
pubmed: 6226722
Nature. 1988 Mar 31;332(6163):411-5
pubmed: 2451132
PLoS One. 2013 Aug 06;8(8):e71145
pubmed: 23940706
N Engl J Med. 2012 Jul 12;367(2):115-23
pubmed: 22784115
Br J Ophthalmol. 2014 Oct;98(10):1368-73
pubmed: 24831719
Mult Scler. 2019 Feb;25(2):224-234
pubmed: 29303033
Clin Exp Ophthalmol. 2018 Dec;46(9):1075-1086
pubmed: 29799159
Neuroepidemiology. 2008;30(4):234-8
pubmed: 18437030
Int J Retina Vitreous. 2015 Apr 15;1:5
pubmed: 27847598
Brain Pathol. 2002 Apr;12(2):154-69
pubmed: 11958369
Biochim Biophys Acta. 2011 Feb;1812(2):141-50
pubmed: 20600869
Neurology. 2010 Mar 30;74(13):1041-7
pubmed: 20350978
N Engl J Med. 2006 Mar 23;354(12):1273-80
pubmed: 16554529
Ann Neurol. 2005 Sep;58(3):383-91
pubmed: 16075460
Exp Ther Med. 2016 Jul;12(1):190-200
pubmed: 27347038
Ophthalmologica. 2016;235(2):65-71
pubmed: 26485541
Acta Neurol Scand Suppl. 1965;15:1-161
pubmed: 5213727
Opt Lett. 2015 May 15;40(10):2305-8
pubmed: 26393725
Brain. 2012 Feb;135(Pt 2):521-33
pubmed: 22006982
J Neurol Sci. 2003 Feb 15;206(2):187-91
pubmed: 12559509
Eye (Lond). 2016 Mar;30(3):456-62
pubmed: 26681148
Tech Vasc Interv Radiol. 2012 Jun;15(2):94-100
pubmed: 22640498
Biomed Res Int. 2014;2014:128517
pubmed: 25313352
Lancet Neurol. 2005 Feb;4(2):111-21
pubmed: 15664543
Med Sci Monit. 2015 Apr 13;21:1066-71
pubmed: 25864450
Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5654-8
pubmed: 23509249
PLoS One. 2011 Apr 06;6(4):e18019
pubmed: 21494672
Eur Radiol. 2015 Jan;25(1):122-31
pubmed: 25129119
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2520-7
pubmed: 10509645
Brain. 2006 Apr;129(Pt 4):1031-9
pubmed: 16495327
Neuroimage. 2009 Aug 15;47(2):773-8
pubmed: 19393745
Handb Clin Neurol. 2014;122:15-58
pubmed: 24507512
Ann Neurol. 2014 Jan;75(1):98-107
pubmed: 24114885
Dev Ophthalmol. 2016;56:6-12
pubmed: 27022989
Brain Pathol. 2007 Apr;17(2):210-8
pubmed: 17388952
Acta Ophthalmol. 2019 Feb;97(1):e77-e83
pubmed: 30239142
J Neurol Neurosurg Psychiatry. 1988 Feb;51(2):260-5
pubmed: 3346691
Mult Scler Int. 2011;2011:472790
pubmed: 22096638
Exp Brain Res. 1984;55(3):483-93
pubmed: 6468554